Allergen immunotherapy: Therapeutic vaccines for allergic diseases - WHO position paper - Geneva, January 27-29, 1991 - Preface

被引：5
作者：
Bousquet, J
Lockey, RF
Malling, HJ
机构：
来源：
REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE | 1999年 / 39卷 / 05期
关键词：
D O I：
10.1016/S0335-7457(99)80137-3
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：399 / 442
页数：44
相关论文
共 420 条
[1]  
AALBERSE RC, 1983, J IMMUNOL, V130, P722
[2]  
ABRAMSON MJ, 1995, AM J RESP CRIT CARE, V151, P969
[3]   HIGH-DOSE INHALED BUDESONIDE IN THE TREATMENT OF SEVERE STEROID-DEPENDENT ASTHMATICS - A 2-YEAR STUDY [J].
ADELROTH, E ;
ROSENHALL, L ;
GLENNOW, C .
ALLERGY, 1985, 40 (01) :58-64
[4]   A controlled trial of immunotherapy for asthma in allergic children [J].
Adkinson, NF ;
Eggleston, PA ;
Eney, D ;
Goldstein, EO ;
Schuberth, KC ;
Bacon, JR ;
Hamilton, RG ;
Weiss, ME ;
Arshad, H ;
Meinert, CL ;
Tonascia, J ;
Wheeler, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (05) :324-331
[5]   Epitope-specific T cell tolerance to phospholipase A(2) in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro [J].
Akdis, CA ;
Akdis, M ;
Blesken, T ;
Wymann, D ;
Alkan, SS ;
Muller, U ;
Blaser, K .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (07) :1676-1683
[6]   MONOCLONAL ANTIBODY-STANDARDIZED CAT EXTRACT IMMUNOTHERAPY - RISK-BENEFIT EFFECTS FROM A DOUBLE-BLIND PLACEBO STUDY [J].
ALVAREZCUESTA, E ;
CUESTAHERRANZ, J ;
PUYANARUIZ, J ;
CUESTAHERRANZ, C ;
BLANCOQUIROS, A .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 93 (03) :556-566
[7]  
*AM AC ALL IMM, 1990, J ALLERGY CLIN IMMUN, V85, P526
[8]  
AMARALMARQUES R, 1978, ALLERGOL IMMUNOPATH, V6, P231
[9]   Delivery systems for immunomodulatory proteins and peptides [J].
Anderson, PM .
BIODRUGS, 1997, 7 (01) :51-65
[10]   LOCAL NASAL IMMUNOTHERAPY IN ALLERGIC RHINITIS TO PARIETARIA - A DOUBLE-BLIND CONTROLLED-STUDY [J].
ANDRI, L ;
SENNA, GE ;
BETTELI, C ;
GIVANNI, S ;
ANDRI, G ;
FALAGIANI, P ;
LUGO, G .
ALLERGY, 1992, 47 (04) :318-323
12345678910